Publications by authors named "P Scheltens"

Claim this Profile
E
Effect of obicetrapib, a potent cholesteryl ester transfer protein inhibitor, on p-tau217 levels in patients with cardiovascular disease.
Michael H Davidson, Michael Szarek, Philip Scheltens, Everard Vijverberg, Andrew Hsieh

J Prev Alzheimers Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of lifestyle factors with amyloid pathology in persons without dementia.
Julie E Oomens, Stephanie Jb Vos, Nancy N Maserejian, Mercè Boada, Mira Didic, Philip Scheltens

J Alzheimers Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease.
Olav M Andersen, Matthijs W J de Waal, Giulia Monti, Niccolo Tesi, Anne Mette G Jensen, Philip Scheltens

Mol Neurodegener· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.
Eleonora M Vromen, Senne B Lageman, Johan Gobom, Rik van der Kant, Valerija Dobricic, Philip Scheltens

Alzheimers Dement· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging the barrier: insights into blood biomarkers and therapeutic strategies targeting choroid plexus and BBB dysfunction in alzheimer's disease.
Niti Sharma, Danyeong Kim, Himadri Sharma, Moon Il Kim, Hyon Lee, Philip Scheltens

Biomark Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis